期刊文献+

冠脉介入治疗对不稳定型心绞痛患者炎症因子及cTnI、MMP-9、NT-pro BNP的影响 被引量:26

Effect of PCI on inflammatory factors,cTnI,MMP-9 and NT-pro BNP in patients with unstable angina pectoris
下载PDF
导出
摘要 目的:探讨冠脉介入治疗对不稳定型心绞痛患者炎症因子及肌钙蛋白I(cTnI)、基质金属蛋白酶-9(MMP-9)、氨基末端脑钠肽前体(NT-pro BNP)的影响。方法 :将80例不稳定型心绞痛患者随机分为观察组和对照组,各40例。观察组行经皮冠脉介入(PCI)治疗,对照组为同期行冠脉造影(CAG)者。分别测定两组患者术前和术后24h血浆炎症因子C反应蛋白(CRP)、白介素-18(IL-18)及cTnI、MMP-9、NT-pro BNP水平,并比较。结果:术后24h,观察组血浆炎症因子CRP、IL-18水平显著升高(P<0.05),对照组无明显变化(P>0.05),两组间差异显著(P<0.05);术后24h,观察组血浆cTnI、MMP-9、NT-pro BNP水平显著升高(P<0.05),对照组无明显变化(P>0.05),两组间差异显著(P<0.05)。结论:PCI治疗会引起不稳定型心绞痛患者炎症因子水平的升高及心肌损伤。 Objective:To investigate the effect of PCI on inflammatory factors,cardiac troponin I(cTnI),matrix metalloproteinase-9(MMP-9)and N-terminal pro-brain natriuretic peptide(NT-pro BNP)in patients with unstable angina pectoris.Methods:A total of 80 unstable angina pectoris patients were divided into observation group(40cases)and control group(40cases).The observation group was given the therapy of percutaneous coronary intervention(PCI),and the control group was given coronary angiography.The of inflammatory factors,cTnI,MMP-9and NT-pro BNP were tested and compared before and after operation.Results:At 24 hafter operation,C-reactive protein(CRP)and interleukin-18(IL-18)levels were increased significantly after treatment in observation group(P〈0.05),there was no difference on inflammatory factors in control group(P〉0.05),and these two groups had significant difference on inflammatory factors(P〈0.05);at 24 hafter operation,cTnI,MMP-9and NT-pro BNP levels were increased significantly after treatment in observation group(P〈0.05),there was no difference on inflammatory factors in control group(P〉0.05),and the two groups had significant difference on inflammatory factors(P〈0.05).Conclusion:PCI therapy can induce inflammation and myocardial injury in patients with unstable angina pectoris.
出处 《海南医学院学报》 CAS 2016年第10期951-953,956,共4页 Journal of Hainan Medical University
基金 黑龙江省卫生厅科研项目(2014156)~~
关键词 冠脉介入 不稳定型心绞痛 炎症因子 肌钙蛋白I(cTnI) 基质金属蛋白酶-9(MMP-9) 氨基末端脑钠肽前体(NT-pro BNP) PCI Unstable angina pectoris Inflammatory factors cTnI MMP-9 NT-pro BNP
  • 相关文献

参考文献20

  • 1Magalhaes MA,Minha S,Chen F,et al.Response to letter regarding article,"Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations"[J].Circulation Cardiovascular Interventions,2015,8(4):210-214.
  • 2李岩.不稳定性心绞痛冠脉介入治疗前后NT-proBNP水平变化观察[J].中国老年保健医学,2015,13(1):46-47. 被引量:1
  • 3Lee K,Yoo SY,Suh J,et al.Efficacy of cilostazol on inhibition of platelet aggregation,inflammation and myonecrosis in acute coronary syndrome patients undergoing percutaneous coronary intervention:The ACCEL-LOADING-ACS(ACCELerated inhibition of platelet aggregation,inflammation and myonecrosis by adjunctive cilostazol loading in patients with acute coronary syndrome)study[J].International Journal of Cardiology,2015,190(2):370-375.
  • 4Kluz K,Parenica J,Kubkova L,et al.Unstable angina pectoris prior to ST elevation myocardial infarction in patients treated with primary percutaneous coronary intervention has no influence on prognosis[J].Biomedical Papers of the Medical Faculty of the University Palacky,Olomouc,Czechoslovakia,2015,159(2):251-258.
  • 5Kizilirmak F,Gunes HM,Demir GG,et al.Impact of intracoronary adenosine on myonecrosis in patients with unstable angina pectoris undergoing percutaneous coronary intervention[J].Cardiovascular Drugs and Therapy/Sponsored by the International Society of Cardiovascular Pharmacotherapy,2015,29(6):519-526.
  • 6王林青.不稳定型心绞痛介入后超敏C反应蛋白与预后的关系研究[J].中国现代药物应用,2015,9(2):40-41. 被引量:3
  • 7Giustino G,Baber U,Stefanini GG,et al.Impact of clinical presentation(stable angina pectoris vs unstable angina pectoris or Non-ST-elevation myocardial infarction vs ST-elevation myocardial infarction)on long-term outcomes in women undergoing percutaneous coronary intervention with drug-eluting stents[J].The American Journal of Cardiology,2015,116(6):845-852.
  • 8赵俊文.冠脉介入对冠心病患者血流及炎症因子的影响[J].实用临床医药杂志,2015,19(5):1-4. 被引量:7
  • 9Zhang XL,Chi YH,Wang le F,et al.Systemic inflammation in patients with chronic obstructive pulmonary disease undergoing percutaneous coronary intervention[J].Respirology,2014,19(5):723-729.
  • 10Sun Fei Yin Zhao Shi Quanxing Zhao Bei Wang Shouli.Effect of short-term high-dose atorvastatin on systemic inflammatory response and myocardial ischemic injury in patients with unstable angina pectoris undergoing percutaneous coronary intervention[J].Chinese Medical Journal,2014(21):3732-3737. 被引量:27

二级参考文献72

  • 1胡章乐,马礼坤.白介素-18与急性冠状动脉综合征[J].国际病理科学与临床杂志,2007,27(1):57-59. 被引量:4
  • 2柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2108
  • 3周丽程,郑杨.脑钠素、N-末端脑钠素前体与心血管疾病[J].中国心血管病研究,2007,5(12):937-939. 被引量:11
  • 4金文君.不稳定型心绞痛介入治疗前后超敏C反应蛋白和肌钙蛋白的变化及其意义.临床外科杂志,2012,22(1):2321-2322.
  • 5中华医学会心血管病学分会.不稳定性心绞痛诊断与治疗指南.中华心血管病杂志,2012,35(3):195-206.
  • 6Serruys PW,de Feyter P,Macaya C. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention:a randomized controlled trial[J].Journal of the American Medical Association,2002,(24):3215-3222.
  • 7Packard RR,Libby P. Inflammation in atherosclerosis:from vascular biology to biomarker discovery and risk prediction[J].Clinical Chemistry,2008,(01):24-38.
  • 8Hansson GK. Inflammation,atherosclerosis,and coronary artery disease[J].New England Journal of Medicine,2005,(16):1685-1695.
  • 9Maffia P,Grassia G,Di Meglio P. Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injury[J].Circulation,2006,(05):430-437.doi:10.1161/CIRCULATIONAHA.105.602714.
  • 10Chandrasekar B,Mummidi S,Mahimainathan L. Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB-and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin[J].Journal of Biological Chemistry,2006,(22):15099-15109.

共引文献72

同被引文献224

引证文献26

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部